Clinical Trial Update: Comparison of Efficacy and Safety of Infant Peri-exposure Prophylaxis With Lopinavir/Ritonavir Versus Lamivudine to Prevent HIV-1 Transmission by Breastfeeding [Phase 3]

View source ↗

Summary

Phase 3 trial comparing infant peri-exposure prophylaxis with Lopinavir/ritonavir versus Lamivudine to prevent HIV transmission during breastfeeding. The study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Lamivudine (lamivudine)
• Lopinavir/ritonavir (lopinavir/ritonavir)

Snippet

Sponsor: French National Agency for Research on AIDS and Viral Hepatitis | Conditions: HIV Infections | Phase 3 | Status: COMPLETED